Robert Lanza, Chief Scientfic Officer at ADVANCED CELL TECHNOLOGY, INC. (ACTC), sold 600,000 shares at $0.08 ($48K) on 2010-08-20, disclosed to the SEC on 2010-08-23.
Open-market sale of $48k ACTC by Chief Scientfic Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.08 | 25,000 | $2K | 4.2% |
| 2 | $0.08 | 29,600 | $2K | 4.9% |
| 3 | $0.08 | 90,700 | $7K | 15.1% |
| 4 | $0.08 | 196,181 | $16K | 32.7% |
| 5 | $0.08 | 258,519 | $21K | 43.1% |
| Total | $0.08 avg | 600,000 |
| $48K |
| 100% |
| Filing → |
| ACTC | SELL | 2012-12-18 | $80K | — | Filing → |
| ACTC | SELL | 2012-08-01 | $160K | — | Filing → |
| ACTC | SELL | 2012-01-25 | $1.4M | — | Filing → |